APA (7th ed.) Citation

Daoussis, D., Liossis, S. C., Tsamandas, A. C., Kalogeropoulou, C., Kazantzi, A., Sirinian, C., . . . Andonopoulos, A. P. (2010). Experience with rituximab in scleroderma: Results from a 1-year, proof-of-principle study. Rheumatology (Oxford, England), 49(2), 271-280. https://doi.org/10.1093/rheumatology/kep093

Chicago Style (17th ed.) Citation

Daoussis, Dimitrios, Stamatis-Nick C. Liossis, Athanassios C. Tsamandas, Christina Kalogeropoulou, Alexandra Kazantzi, Chaido Sirinian, Maria Karampetsou, Georgios Yiannopoulos, and Andrew P. Andonopoulos. "Experience with Rituximab in Scleroderma: Results from a 1-year, Proof-of-principle Study." Rheumatology (Oxford, England) 49, no. 2 (2010): 271-280. https://doi.org/10.1093/rheumatology/kep093.

MLA (9th ed.) Citation

Daoussis, Dimitrios, et al. "Experience with Rituximab in Scleroderma: Results from a 1-year, Proof-of-principle Study." Rheumatology (Oxford, England), vol. 49, no. 2, 2010, pp. 271-280, https://doi.org/10.1093/rheumatology/kep093.